Blood drug levels may predict recovery after brain bleed

NCT ID NCT07065903

Recruiting now Knowledge-focused Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 500 adults in Canada and the US who have had a brain aneurysm bleed and are taking the drug nimodipine. Researchers will measure how much of the drug gets into each patient's blood and see how that relates to their recovery 90 days later. The goal is to understand if different doses or forms of nimodipine affect outcomes, which could lead to more personalized treatment in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nimodipine
What this could lead to: If successful, this could lead to personalized nimodipine dosing for patients with brain aneurysm bleeds, potentially improving recovery and reducing disability.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may show associations but not prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBARACHNOID ANEURYSM HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage subarachnoid hemorrhage

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SUBARACHNOID ANEURYSM HEMORRHAGE SUBARACHNOID HEMORRHAGE, ANEURYSMAL

Contacts and locations

Locations

University Health Network - Toronto Western Hospital
RECRUITING

Toronto, Ontario, M5T 2S8, Canada
University of Alberta Hospital
RECRUITING

Edmonton, Alberta, T6G 2X8, Canada
VCU Medical Center
RECRUITING

Richmond, Virginia, 23219, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.